235 related articles for article (PubMed ID: 12459786)
21. HIV: Bad news for stop--start therapy?
McMichael AJ; Rowland-Jones SL
Nature; 2002 Nov; 420(6914):371, 373. PubMed ID: 12459769
[No Abstract] [Full Text] [Related]
22. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
Cao J; McNevin J; Holte S; Fink L; Corey L; McElrath MJ
J Virol; 2003 Jun; 77(12):6867-78. PubMed ID: 12768006
[TBL] [Abstract][Full Text] [Related]
23. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD
J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094
[TBL] [Abstract][Full Text] [Related]
24. A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up.
Caetano DG; Côrtes FH; Bello G; de Azevedo SSD; Hoagland B; Villela LM; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
BMC Infect Dis; 2019 Jul; 19(1):588. PubMed ID: 31277590
[TBL] [Abstract][Full Text] [Related]
25. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.
Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou J; Johnston MN; Gao F; Walker BD; Rosenberg ES
J Immunol; 2003 Apr; 170(7):3906-14. PubMed ID: 12646660
[TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J
J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902
[TBL] [Abstract][Full Text] [Related]
27. Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response.
Locher CP; Blackbourn DJ; Barnett SW; Murthy KK; Cobb EK; Rouse S; Greco G; Reyes-Terán G; Brasky KM; Carey KD; Levy JA
J Infect Dis; 1997 Oct; 176(4):948-59. PubMed ID: 9333153
[TBL] [Abstract][Full Text] [Related]
28. Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor.
Saha K; Zhang J; Gupta A; Dave R; Yimen M; Zerhouni B
Nat Med; 2001 Jan; 7(1):65-72. PubMed ID: 11135618
[TBL] [Abstract][Full Text] [Related]
29. Immune-driven recombination and loss of control after HIV superinfection.
Streeck H; Li B; Poon AF; Schneidewind A; Gladden AD; Power KA; Daskalakis D; Bazner S; Zuniga R; Brander C; Rosenberg ES; Frost SD; Altfeld M; Allen TM
J Exp Med; 2008 Aug; 205(8):1789-96. PubMed ID: 18625749
[TBL] [Abstract][Full Text] [Related]
30. Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection.
Day CL; Kiepiela P; Leslie AJ; van der Stok M; Nair K; Ismail N; Honeyborne I; Crawford H; Coovadia HM; Goulder PJ; Walker BD; Klenerman P
J Virol; 2007 Jan; 81(1):434-8. PubMed ID: 17050606
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.
Wang B; Dyer WB; Zaunders JJ; Mikhail M; Sullivan JS; Williams L; Haddad DN; Harris G; Holt JA; Cooper DA; Miranda-Saksena M; Boadle R; Kelleher AD; Saksena NK
Virology; 2002 Dec; 304(2):246-64. PubMed ID: 12504566
[TBL] [Abstract][Full Text] [Related]
32. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
[TBL] [Abstract][Full Text] [Related]
33. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance.
Wodarz D
J Theor Biol; 2001 Dec; 213(3):447-59. PubMed ID: 11735291
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.
Yang OO; Daar ES; Jamieson BD; Balamurugan A; Smith DM; Pitt JA; Petropoulos CJ; Richman DD; Little SJ; Brown AJ
J Virol; 2005 Jan; 79(2):860-8. PubMed ID: 15613314
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity.
Lichterfeld M; Yu XG; Cohen D; Addo MM; Malenfant J; Perkins B; Pae E; Johnston MN; Strick D; Allen TM; Rosenberg ES; Korber B; Walker BD; Altfeld M
AIDS; 2004 Jul; 18(10):1383-92. PubMed ID: 15199314
[TBL] [Abstract][Full Text] [Related]
36. Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection.
Radebe M; Nair K; Chonco F; Bishop K; Wright JK; van der Stok M; Bassett IV; Mncube Z; Altfeld M; Walker BD; Ndung'u T
J Infect Dis; 2011 Sep; 204(5):768-76. PubMed ID: 21844303
[TBL] [Abstract][Full Text] [Related]
37. Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15.
Chitnis V; Pahwa R; Pahwa S
Clin Immunol; 2003 Apr; 107(1):36-45. PubMed ID: 12738248
[TBL] [Abstract][Full Text] [Related]
38. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.
Cao J; McNevin J; Malhotra U; McElrath MJ
J Immunol; 2003 Oct; 171(7):3837-46. PubMed ID: 14500685
[TBL] [Abstract][Full Text] [Related]
39. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication.
Buseyne F; Le Gall S; Boccaccio C; Abastado JP; Lifson JD; Arthur LO; Rivière Y; Heard JM; Schwartz O
Nat Med; 2001 Mar; 7(3):344-9. PubMed ID: 11231634
[TBL] [Abstract][Full Text] [Related]
40. HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.
de Azevedo SSD; Delatorre E; Côrtes FH; Hoagland B; Grinsztejn B; Veloso VG; Souza TML; Morgado MG; Bello G
AIDS; 2019 Mar; 33(3):399-410. PubMed ID: 30531316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
